【2h】

MicroRNAs in biliary diseases

机译:胆道疾病中的MicroRNA

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cholangiopathies are a group of diseases primarily or secondarily affecting bile duct cells, and result in cholangiocyte proliferation, regression, and/or transformation. Their etiopathogenesis may be associated with a broad variety of causes of different nature, which includes genetic, neoplastic, immune-associated, infectious, vascular, and drug-induced alterations, or being idiopathic. miRNAs, small non-coding endogenous RNAs that post-transcriptionally regulate gene expression, have been associated with pathophysiological processes in different organs and cell types, and are postulated as potential targets for diagnosis and therapy. In the current manuscript, knowledge regarding the role of miRNAs in the development and/or progression of cholangiopathies has been reviewed and the most relevant findings in this promising field of hepatology have been highlighted.
机译:胆管病是一组主要或次要影响胆管细胞的疾病,并导致胆管细胞增殖,消退和/或转化。它们的病因可能与多种不同性质的原因有关,包括遗传,肿瘤,免疫相关,传染性,血管性和药物诱导的改变或特发性。 miRNA是转录后调节基因表达的小型非编码内源性RNA,已与不同器官和细胞类型的病理生理过程相关,并被假定为诊断和治疗的潜在靶标。在当前的手稿中,已综述了有关miRNA在胆管病的发展和/或进展中的作用的知识,并着重指出了这一有希望的肝病学领域中最相关的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号